Click to open contact form.
Your Global Partners in the Business of Innovation

Akari Therapeutics Opens Trade on NASDAQ Stock Market

Publications / Dec 11, 2015

Senior Partner Mark Cohen, Chair of the Life Science Practice Group and Vice Chairman of the Board of Akari Therapeutics, participated on Monday in the opening trade ceremony and rang the bell at NASDAQ.

Akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan and rare autoimmune and inflammatory diseases. It is now traded on NASDAQ under the ticket AKTX.

CLICK HERE to view the pictures from the ceremony.

INNOVATION HIGHLIGHTS